Home / Ophthalmology / Glaucoma

Acute Angle-Closure Glaucoma Presentation: Etiological Triggers & Risks (Genomic Subtype Study)

Glaucoma Specialty Division
■ LECTURE OVERVIEW: Acute Angle-Closure Glaucoma is a sight-threatening medical emergency characterized by a sudden block in the outflow of aqueous humor, leading to a critical rise in intraocular pressure (IOP). ■ MOLECULAR & STRUCTURAL PATHOLOGY: 1. Pupil Blockage: In structurally predisposed eyes (e.g., hyperopic eyes with shallow anterior chambers), pupillary dilation brings the peripheral iris into contact with the lens. This blocks the passage of aqueous humor from the posterior chamber to the anterior chamber. 2. Iris Bowing: Trapped aqueous humor builds pressure behind the iris, bowing it forward (iris bombé). 3. Trabecular Occlusion: The peripheral bowed iris makes physical contact with the trabecular meshwork, completely closing the drainage angle. 4. Critical IOP Surge: Aqueous humor production continues, but drainage is blocked, causing IOP to surge from a normal range of 10-21 mmHg up to 50-80 mmHg, compressing the optic nerve. ■ ETIOLOGICAL PROFILE & RISK FACTORS: Major etiological drivers include genetic predispositions (autosomal patterns and chromosomal translocations) and environmental triggers like toxic chemical exposure, mechanical stress, or chronic viral infections. ■ GENOMIC VARIANT CHARACTERISTICS: Molecular profiling indicates that specific genetic subtypes exhibit varying levels of enzyme activity and drug-clearance efficiency. [HY-BOARD-1103]

🌟 Dynamic Clinical Key:

Presents acutely with severe, unilateral eye pain, headache, nausea, blurred vision, and halos around lights. Examination reveals conjunctival injection, a cloudy and edematous cornea, and a fixed, mid-dilated pupil. Emergency treatment requires systemic acetazolamide, topical pilocarpine, and definitive laser peripheral iridotomy. Assess family history and genetic screens to identify high-risk patients before symptoms present. Genetic screening profiles can help tailor precise therapeutic doses for optimal patient outcomes.

Professional Medical Reference Application v2.5

For training, board examinations (USMLE, PLAB), and clinician benchmarking. Do not replace professional care.